Orgenesis Inc. (NASDAQ:ORGS – Get Free Report) was up 8.2% during mid-day trading on Thursday . The company traded as high as $3.64 and last traded at $3.45. Approximately 3,608 shares changed hands during trading, a decline of 74% from the average daily volume of 14,147 shares. The stock had previously closed at $3.19.
Orgenesis Price Performance
The firm’s 50-day simple moving average is $2.17.
About Orgenesis
Orgenesis Inc, a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals.
Further Reading
- Five stocks we like better than Orgenesis
- What is a support level?
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- The 3 Best Retail Stocks to Shop for in August
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
